✦ LIBER ✦

109 Potential of survivin as a new therapeutic target in diffuse malignant mesothelioma of the peritoneum

✍ Scribed by Zaffaroni, N.; Costa, A.; Pennati, M.; De Marco, C.; Erdas, R.; Kusamura, S.; Deraco, M.; Daidone, M.G.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diffuse malignant epithelial mesotheliom

✍ Scott A. J. Kerrigan; Rael T. Turnnir; Philip B. Clement; Robert H. Young; Andre 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

Molecular profiling of malignant periton

✍ Borczuk, A C; Cappellini, G C A; Kim, H K; Hesdorffer, M; Taub, R N; Powell, C A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 285 KB

The role of survivin as a new target of

✍ Tetsuhisa Yamamoto; N. Tanigawa 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 181 KB

The use of antisense oligonucleotides in

✍ Eric T. Shinohara; Dennis E. Hallahan; Bo Lu 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 319 KB

The significance of TP53 in lymphoid mal

✍ K-John J. Cheung; Douglas E. Horsman; Randy D. Gascoyne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

FGFR3 as a therapeutic target of the sma

✍ Chen, Jing; Lee, Benjamin H; Williams, Ifor R; Kutok, Jeffery L; Mitsiades, Cons 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 403 KB